Ara
Toplam kayıt 2, listelenen: 1-2
A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?
(AVES, 2015)
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese patients require dose adjustment according to ...
Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight
(Turkish Society of Cardiology, 2016)
We have read with great interest the manuscript by Housseinsabet (1) entitled “Assessment of atrial conduction times in patients with mild diastolic dysfunction and normal atrial size,” published in the Anatolian Journal ...